• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[镓]镓-FAPI PET/CT在脑肿瘤中的应用:与[氟]氟-FDG PET/CT的比较。

[Ga]Ga-FAPI PET/CT in brain tumors: comparison with [F]F-FDG PET/CT.

作者信息

Liu Ya, Ding Haoyuan, Cao Jianpeng, Liu Guangfu, Chen Yue, Huang Zhanwen

机构信息

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.

出版信息

Front Oncol. 2024 Sep 6;14:1436009. doi: 10.3389/fonc.2024.1436009. eCollection 2024.

DOI:10.3389/fonc.2024.1436009
PMID:39309741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11412958/
Abstract

PURPOSE

To investigate the feasibility of [Ga]Ga-FAPI PET/CT in brain tumor imaging and to compare it with [F]F-FDG PET/CT.

METHODS

25 patients with MRI-suspected brain tumors were included in the study. They underwent whole body [F]F-FDG PET/CT and [Ga]Ga-FAPI PET/CT and brain scans. The target-to-background ratio (TBR) of brain tumors was calculated with the background of surrounding normal brain tissues uptake. The SUVmax and TBR of [F]F-FDG PET/CT and [Ga]Ga-FAPI PET/CT were compared. Additionally, the correlation between the uptake of the tracer by lesions with the greatest diameter of the lesion, the breadth of the oedema band, and the enhancement scores of the MRI enhancement scans was analyzed.

RESULT

[Ga]Ga-FAPI PET/CT was superior to [F]F-FDG PET/CT for lesion detection, especially for brain metastases. Among gliomas, only high-grade gliomas uptake [Ga]Ga-FAPI. Compared with [F]F-FDG PET/CT, [Ga]Ga-FAPI PET/CT had a lower SUVmax but a significantly better TBR. On [Ga]Ga-FAPI PET/CT, the TBR may be associated with brain tumor blood-brain barrier disruption.

CONCLUSIONS

[Ga]Ga-FAPI PET/CT is a promising imaging tool for the assessment of brain tumors. Lack of physiological uptake of [Ga]Ga-FAPI in normal brain parenchyma results in high TBR values, leading to better visualization of lesions and contributing to subsequent targeted therapy studies.

ADVANCES IN KNOWLEDGE

Clinical utility of [Ga]Ga-FAPI PET/CT in brain tumors remains unclear, and there aren't many similar studies in the literature. We evaluated the role of [Ga]Ga-FAPI PET/CT in diagnosing brain tumors.

摘要

目的

探讨[镓]镓-FAPI PET/CT在脑肿瘤成像中的可行性,并将其与[氟]氟-FDG PET/CT进行比较。

方法

本研究纳入25例MRI怀疑患有脑肿瘤的患者。他们接受了全身[氟]氟-FDG PET/CT和[镓]镓-FAPI PET/CT检查及脑部扫描。以周围正常脑组织摄取为背景计算脑肿瘤的靶本底比(TBR)。比较[氟]氟-FDG PET/CT和[镓]镓-FAPI PET/CT的SUVmax和TBR。此外,分析了病灶摄取示踪剂与最大病灶直径、水肿带宽度以及MRI增强扫描强化评分之间的相关性。

结果

[镓]镓-FAPI PET/CT在病灶检测方面优于[氟]氟-FDG PET/CT,尤其是在脑转移瘤方面。在胶质瘤中,只有高级别胶质瘤摄取[镓]镓-FAPI。与[氟]氟-FDG PET/CT相比,[镓]镓-FAPI PET/CT的SUVmax较低,但TBR明显更好。在[镓]镓-FAPI PET/CT上,TBR可能与脑肿瘤血脑屏障破坏有关。

结论

[镓]镓-FAPI PET/CT是一种有前景的脑肿瘤评估成像工具。正常脑实质中[镓]镓-FAPI缺乏生理性摄取导致高TBR值,从而使病灶显示更好,并有助于后续的靶向治疗研究。

知识进展

[镓]镓-FAPI PET/CT在脑肿瘤中的临床应用仍不明确,文献中类似研究较少。我们评估了[镓]镓-FAPI PET/CT在诊断脑肿瘤中的作用。

相似文献

1
[Ga]Ga-FAPI PET/CT in brain tumors: comparison with [F]F-FDG PET/CT.[镓]镓-FAPI PET/CT在脑肿瘤中的应用:与[氟]氟-FDG PET/CT的比较。
Front Oncol. 2024 Sep 6;14:1436009. doi: 10.3389/fonc.2024.1436009. eCollection 2024.
2
Comparison of [Ga]Ga-FAPI and [F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study.胃印戒细胞癌患者[Ga]Ga-FAPI 和 [F]FDG 摄取的比较:一项多中心回顾性研究。
Eur Radiol. 2023 Feb;33(2):1329-1341. doi: 10.1007/s00330-022-09084-9. Epub 2022 Aug 17.
3
Comparison of Ga-FAPI and F-FDG PET/CT in the Evaluation of Advanced Lung Cancer.Ga-FAPI 与 F-FDG PET/CT 在晚期肺癌评估中的比较。
Radiology. 2022 Apr;303(1):191-199. doi: 10.1148/radiol.211424. Epub 2022 Jan 4.
4
Comparison of Ga-FAPI and F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer.镓标记的纤维连接蛋白激活肽成像(Ga-FAPI)与氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)在初诊非小细胞肺癌患者评估中的比较
Front Oncol. 2022 Jul 4;12:924223. doi: 10.3389/fonc.2022.924223. eCollection 2022.
5
[Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [F]FDG PET/CT.镓[^68^Ga]镓[^18^F]双半胱氨酸二肽[FAPI]-04 正电子发射断层扫描/计算机断层扫描(PET/CT)在胃癌评估中的应用:与[^18^F]氟脱氧葡萄糖(FDG)PET/CT 的比较。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2960-2971. doi: 10.1007/s00259-022-05799-5. Epub 2022 Apr 25.
6
The potential utility of [ Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [F]FDG.[68Ga]Ga-DOTA-FAPI-04 作为一种新型广谱肿瘤和非肿瘤成像剂的潜在应用——与[18F]FDG 比较。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):963-979. doi: 10.1007/s00259-021-05522-w. Epub 2021 Aug 19.
7
Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET/CT in cancer patients.头对头个体内比较 Ga-FAPI 和 F-FDG PET/CT 在癌症患者中的生物分布和肿瘤摄取。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385. doi: 10.1007/s00259-021-05307-1. Epub 2021 Jun 17.
8
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.[68Ga]Ga-成纤维细胞激活蛋白抑制剂-04 PET/CT 在肾细胞癌中的初步研究。
Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025.
9
Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the F-FDG PET/CT.镓标记的FAPI-04 PET/CT,乳腺癌成像的新进展:与氟代脱氧葡萄糖(FDG)PET/CT的对比性初步研究
Ann Nucl Med. 2021 Jun;35(6):744-752. doi: 10.1007/s12149-021-01616-5. Epub 2021 May 2.
10
Usefulness of [Ga]FAPI-04 and [F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study.[镓]FAPI-04和[氟]FDG PET/CT在胃肠道癌原发肿瘤及转移灶检测中的应用:一项对比研究
Eur Radiol. 2023 Apr;33(4):2779-2791. doi: 10.1007/s00330-022-09251-y. Epub 2022 Nov 17.

引用本文的文献

1
The superiority of [Ga]Ga-FAPI PET/CT over MRI and [F]FDG PET/CT in delineating a rare case of pituitary fibrosarcoma.[镓]Ga-FAPI PET/CT在诊断一例罕见的垂体纤维肉瘤中相对于MRI和[氟]FDG PET/CT的优势。
Eur J Nucl Med Mol Imaging. 2025 Jul 31. doi: 10.1007/s00259-025-07467-w.
2
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.基于成纤维细胞活化蛋白抑制剂(FAPI)的诊疗一体化
Pharmaceuticals (Basel). 2025 Apr 3;18(4):522. doi: 10.3390/ph18040522.
3
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?

本文引用的文献

1
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China.成纤维细胞激活蛋白抑制剂示踪剂及其在中国的临床前、转化和临床研究现状。
J Nucl Med. 2024 May 6;65(Suppl 1):4S-11S. doi: 10.2967/jnumed.123.266983.
2
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.脑肿瘤患者正电子发射断层扫描和高级磁共振成像的挑战、局限性和陷阱:PET/RANO 小组的报告。
Neuro Oncol. 2024 Jul 5;26(7):1181-1194. doi: 10.1093/neuonc/noae049.
3
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotracers.
FAPI放射性药物在实体肿瘤的核肿瘤学与诊疗一体化中的应用:我们离攻克癌症的特征更近了吗?
Ann Nucl Med. 2025 May;39(5):407-423. doi: 10.1007/s12149-025-02022-x. Epub 2025 Mar 11.
4
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma.SSTR2a、FAP、HER2和HER3作为高级别脑膜瘤潜在放射性核素治疗靶点的表达
Eur J Nucl Med Mol Imaging. 2025 Jan 16. doi: 10.1007/s00259-025-07075-8.
人工智能在肿瘤分子 PET 成像中的应用:超越 [F]F-FDG 示踪剂的叙述性综述 第二部分。[F]F-FLT、[F]F-FET、[C]C-MET 和其他较少使用的放射性示踪剂。
Semin Nucl Med. 2024 Mar;54(2):293-301. doi: 10.1053/j.semnuclmed.2024.01.002. Epub 2024 Feb 7.
4
Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study.镓标记的FAPI-04 PET-CT用于系统性硬化症相关间质性肺疾病中纤维母细胞活化的分子评估及风险评估:一项单中心试点研究
Lancet Rheumatol. 2021 Mar;3(3):e185-e194. doi: 10.1016/S2665-9913(20)30421-5. Epub 2021 Jan 25.
5
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.成纤维细胞活化蛋白抑制剂-PET/CT的近期研究主题:临床与药理学方面
Ann Nucl Med. 2024 Jan;38(1):10-19. doi: 10.1007/s12149-023-01873-6. Epub 2023 Oct 20.
6
From FDG and beyond: the evolving potential of nuclear medicine.从氟代脱氧葡萄糖(FDG)及其他方面:核医学不断发展的潜力
Ann Nucl Med. 2023 Nov;37(11):583-595. doi: 10.1007/s12149-023-01865-6. Epub 2023 Sep 25.
7
Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.68Ga-FAPI-46 对 SMARCA4 缺陷型胃未分化癌 18F-FDG PET/CT 检查中转移病灶的高识别度 **注意**:这是一个翻译示例,原文和译文都可能存在错误,仅供参考。
Clin Nucl Med. 2023 Nov 1;48(11):1009-1011. doi: 10.1097/RLU.0000000000004860. Epub 2023 Sep 12.
8
Understanding the Value of FAPI versus FDG PET/CT in Primary and Metastatic Lung Cancer.了解FAPI与FDG PET/CT在原发性和转移性肺癌中的价值。
Radiology. 2023 Aug;308(2):e231768. doi: 10.1148/radiol.231768.
9
Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of Ga-FAPI PET/CT and F-FDG PET/CT.成纤维细胞激活蛋白与淋巴瘤诊断中的糖酵解:Ga-FAPI PET/CT 与 F-FDG PET/CT 的比较。
J Nucl Med. 2023 Sep;64(9):1399-1405. doi: 10.2967/jnumed.123.265530. Epub 2023 Jun 29.
10
Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis.FAPI PET/CT 在肿瘤学研究中的诊断准确性评估:系统评价和荟萃分析。
J Nucl Med. 2023 Aug;64(8):1218-1224. doi: 10.2967/jnumed.123.265471. Epub 2023 Jun 8.